• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Study reveals how enzyme detects ultraviolet light damage

Bioengineer by Bioengineer
August 22, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Image collage courtesy of Dong Wang, UC San Diego

Damage to DNA is a constant threat to cellular life, and so it is constantly monitored and detected by a family of enzymes called RNA polymerases, resulting in subsequent repair to maintain genome integrity. In a paper published this week in the journal PNAS, researchers at University of California San Diego School of Medicine, with colleagues in Spain and Finland, describe for the first time how one type of RNA polymerase gets stalled by DNA lesions caused by exposure to ultraviolet (UV) light.

Called thymine dimers, DNA lesions are damage sites to the base pairs that comprise the structure of DNA. The DNA lesions are caused by exposure to UV light, such as sunlight, which causes neighboring thymine base pairs to bond, disrupting the DNA strand. Untreated, these lesions may eventually result in cancerous growths, such as melanoma.

RNA polymerase I (Pol I) is an enzyme responsible for up to 60 percent of total transcriptional activity in growing cells. It is a key determinant for cell growth control, and is also responsible for identifying lesions and activating repairs at the rDNA region, a DNA sequence that codes for ribosomal RNA.

"It's the most active RNA polymerase in growing cells and so its ability to identify lesions has significant influence on whether a cell can survive UV-caused genetic damage," said co-corresponding author Dong Wang, PhD, associate professor in the Skaggs School of Pharmacy and Pharmaceutical Sciences and the Department of Cellular and Molecular Medicine at UC San Diego. "However, little is known about how this enzyme actually processes UV-induced lesions."

In the new study, Wang's lab, in collaboration with Carlos Fenandez-Tornero, PhD, molecular biologist, and colleagues at the Spanish National Research Council in Madrid, combined in vitro enzymatic activity studies with electron cryomicroscopy to characterize the mechanisms that stall Pol I as it approaches a lesion to begin recruiting proteins responsible for DNA repair. They found that Pol I is able to sense the DNA lesion through specific interactions with both the damaged base and the DNA backbone, stalling right before the lesion reaches the active site of RNA Pol I.

Additionally, the study identified a key amino acid among more than 5,000 that constitute Pol I that is essential to detecting DNA lesions formed by UV damage. Interestingly, this Pol I-specific residue does not exist in other forms RNA polymerases. Mutation studies suggest that this residue is important in controlling the polymerase stall profile at DNA lesions.

Because RNA Pol I is a key determinant for cell growth control, it is also an attractive cancer therapeutic target, said Wang, who suggested the findings could open a new avenue for the development of novel anticancer drugs that target RNA Pol I transcription machinery.

###

Co-authors include: Marta Sanz-Murillo and Maria Moreno-Morcillo, Spanish National Research Council; Jun Xu, UC San Diego; Georgiy A. Belogurov, University of Turku, Finland; Olga Calvo, Spanish National Research Council and University of Salamanca, Spain; and David Gil-Carton, Cooperative Center for Research in Biosciences, Spain.

Media Contact

Scott LaFee
[email protected]
858-249-0456
@UCSanDiego

http://www.ucsd.edu

Share12Tweet8Share2ShareShareShare2

Related Posts

Menopause Care: Insights from Workforce Review and Consultation

February 7, 2026

LRRK2R1627P Mutation Boosts Gut Inflammation, α-Synuclein

February 7, 2026

3D Gut-Brain-Vascular Model Reveals Disease Links

February 7, 2026

Low-Inflammation in Elderly UTIs: Risks and Resistance

February 7, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Menopause Care: Insights from Workforce Review and Consultation

LRRK2R1627P Mutation Boosts Gut Inflammation, α-Synuclein

3D Gut-Brain-Vascular Model Reveals Disease Links

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.